Quick summary: Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours .
Public recall detail
Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours .
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Brand
Affected products
Issue
What you should do
- Patients should watch for unusual impulse-related behaviours and report them to their healthcare professional. This includes an uncontrollable impulse to gamble, unusual sexual thoughts, fantasies, desires or behaviours, or any other uncontrollable behaviours that they find distressing while being treated with Abilify or Abilify Maintena.
- Patients who have had a gambling disorder in the past may be at an increased risk of pathological gambling and should be monitored carefully by their healthcare professional.
- Talk to your doctor if you have any questions or concerns about your treatment with Abilify or Abilify Maintena.
- To work properly, Abilify (tablet form) should be taken every day as prescribed. Do not stop taking Abilify or change your dose without first consulting your doctor.
Additional official information
Background{}
Companies
Audiences
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.